Position in GRFS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,430
-$1,096 QoQ
Shares Held
202
-35.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#149
of 164 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $119,634,223 across 18 Drug Manufacturers - General names. GRFS ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,933 | $38,301,401 | |
| 2 | ABBV |
AbbVie Inc.
|
100,846 | $25,376,887 | |
| 3 | JNJ |
Johnson & Johnson
|
83,035 | $21,088,398 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
76,862 | $9,710,745 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,774 | $8,580,459 | |
| 6 | AMGN |
Amgen Inc
|
11,139 | $4,033,654 | |
| 7 | NVO |
Novo Nordisk A S
|
56,877 | $2,726,683 | |
| 8 | NVS |
Novartis AG
|
15,640 | $2,451,100 |
All Filings in GRFS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,430 | 202 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,526 | 315 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,964 | 424 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,569 | 258 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,826 | 202 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $7,230 | 1,017 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $6,368 | 856 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,139 | 804 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,341 | 688 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $10,714 | 1,604 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $24,726 | 2,139 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,571 | 1,266 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $11,477 | 1,253 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $9,183 | 1,246 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $10,888 | 1,281 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $20,685 | 3,358 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $46,415 | 3,907 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $41,802 | 3,579 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $48,962 | 4,360 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $8,999 | 616 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $5,482 | 316 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,818 | 163 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $11,469 | 622 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $6,714 | 387 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $3,210 | 176 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $12,829 | 637 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||